Finance for Growth course

Valuating and financing Life Sciences & Health SMEs for Growth

Are you an entrepreneur seeking investments and aiming for clear and convincing investment propositions? Or are you a Tech Transfer Officer, a Business Analyst or a Policy Maker or Advisor who needs to thoroughly evaluate business proposals and business cases? Then, gain insights in valuating and financing Life Sciences & Health SMEs through this course Financing for Growth, organised by Vrije Universiteit Amsterdam.

Based upon real case studies within the Health and Life Sciences sector you will learn all the ins and outs of the fundamentals of strategic financing, the theory and practice of valuation and practical aspects of incorporation.

Participant Profile
> Entrepreneurs
> Tech Transfer Officers
> Investment analysts
> Policy makers

The course is composed of seven days, all Fridays, in November and December 2019.

The course will be concluded with an exam on 20 December 2019.


 Dates Module Content 
 1 Nov 2019 1. The basics of strategic funding: market trends and financial statement analysis
  • Why and how does the biopharma market differ from traditional markets in terms of financing?
  • What to learn from financial statements? The basics of reading and interpreting balance sheets, profit and loss statements and cash flow statements
 8 Nov 2019 2. Financial feasibility: smart calculations, financing of early stage ventures and getting new products reimbursed
  • How to conduct smart calculations with a common spreadsheet tool: advanced use of Excel functions
  • What role do budget impact and incremental cost-effectiveness play in evaluating biotech projects?
  • How do I finance a business? Applying non-dilutive funding to finance life sciences ventures
 15 Nov 2019 3. Negotiating a deal: the time value of money, capital budgeting, and deal terms
  • Why the profits in pharma need to be high, or: the time value of money and capital budgeting?
  • What to look for when negotiating with venture capital? The most often used venture capital deal terms and the most overlooked clauses.
 22 Nov 2019 4. The impact of risk and return: cost of capital and industry specific margins
  • When it might be better to wait. Using real options in the biopharma sector.
  • How do venture capitalists valuate companies before they invest? Experiences from a seasoned investor
 29 Nov 2019 5. Valuating your company: your approach and the approach of the VC
  • How much is my company worth? Applying different techniques to valuate companies?
  • How much is my company worth? Understanding industry specific costs, revenues, margins and risk profiling
 6 Dec 2019 6. Securing an exit: perspectives of investment bankers and valuation of M&A deals
  • Mergers and acquisitions to further your innovation: how do they work and what is their value?
  • What to take into account when selling your company: real-life examples on how investment bankers evaluate your company?
 13 Dec 2019 7. Get active: understanding and applying 24 financing modalities while keeping in control of your finances and optimizing your fiscal position
  • Understanding and applying over 24 financing modalities for your firm (with an emphasis on non-dilutive instruments).
  • How to keep in control of your company's finances and optimize your fiscal position. Practical, fiscal and accountancy aspects of incorporation and financing in the Life Sciences?
  • When standard financing modalities are not enough. The use of crowdfunding in health and life sciences.

Program Director

Eric Claassen, Professor Business Management & Entrepreneurship in Health & Life Sciences at Vrije Universiteit Amsterdam

> Apply soon as places are limited!
> Standard fee for the course: €2,850
> Participation in separate modules instead of the entire course is possible. Fee per module is €500
> Deadline of registration is 15 October 2019
All prices are excl. VAT.
The fee for the full course includes the books Venture Capital Deal Terms by Harm de Vries and Corporate Finance by Berk and Demarzo.

ECTS credited
The course has a study load of 6 ECTS (168 hours). You will receive a certificate of attendance after finalizing the course.


Download the brochure of the Finance for Growth course from 2019 for more information.


Click here to register for this course.

More info

If you have questions about the program, please contact Dr. Linda van de Burgwal of the VU University at If you have questions about the registration and invoice, please contact us at


Join the community of BDP Life Sciences of Business Development professionals and Business leaders in Life Sciences & Health. Through our programmes you will connect with fellow participants, our speakers, coaches and alumni. Also connect with us online via LinkedIn.


Contribute to the development of future business leaders in Life Sciences & Health by becoming a speaker, mentor or sponsor of our programmes. Contact us to discuss the possibilities via info[at] 


Are you looking for a Business Development professional? Our partner PRIMER BioBusiness is specialised in the recruitment of commercial talent for the Life Sciences. Whether you need new talent, experienced professional ar an executive to lead your company, contact us to start your search.